Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01336205 · ClinicalTrials.gov registry record · Phase 3
Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
A Phase 3 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 3
- Development phase
- 844
- Enrollment target
NCT01336205: Completed Phase 3 study, sponsored by AstraZeneca.
NCT01336205 is a Phase 3 study that has completed, run by AstraZeneca. The registered enrollment target is 844 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01336205, a Phase 3 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 844 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
Primary Outcome
The incidence of patients experiencing at least one AE during the randomized treatment and follow-up periods was calculated.
Interventions
- DRUG Usual care
- DRUG NKTR-118
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 844 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
What the finished NCT01336205 record still lists
NCT01336205 is an interventional study that assigns participants to a tested intervention. The registered 844 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT01336205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01336205 about?
NCT01336205 is a clinical study titled "Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation". The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
What is the current status of trial NCT01336205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 844 participants. The study started on 2011-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01336205?
The interventions under investigation include: Usual care (DRUG), NKTR-118 (DRUG).
Who is sponsoring clinical trial NCT01336205?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01336205's enrollment target sits among peer trials
844 391st of 2000 higher than 1,609 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06747949 · 844 participants · Phase 3
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- NCT02757859 · 845 participants · NA
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
- NCT06439979 · 843 participants · NA
Rural Adult and Youth Sun Protection Study
- NCT06027788 · 842 participants · NA
CTSN Embolic Protection Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia